l carnitina para la celulitis SOLUCION L-CARNITINA Adiós Celulitis Healthy Fusion |
Description
H.SlamtiL.AvciF
doi: 10.1126/science.1065874
Currently, the dual IGF1/2-neutralizing antibody xentuzumab in combination with everolimus and exemestane is subject to clinical trial in ER + /ErbB2 - breast cancer
Rosa Mara Martnez-Espinosa conceived and designed the systematic search, contributed to the selection of the information of interest in tables and figures, and wrote the paper
